BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Watson Pharmaceuticals, Inc. 

400 Interpace Parkway

Parsippany  New Jersey  07054  U.S.A.
Phone: 862-261-7000 or 800-900-1644 (US Toll Free) Fax: n/a


SEARCH JOBS


About Watson
Watson Pharmaceuticals, Inc.
is a dynamic organization of more than 6,500 scientists, technicians, sales and marketing, administrative, manufacturing and business professionals working together to achieve our global mission: to help others achieve a better quality of life.

Every day, our talented, passionate global teams engage to develop, manufacture, market, sell and distribute generic, brand and biologic pharmaceutical products.

Our Global Success
Within our Global Generics business, we are the third leading manufacturer of generic medicines in the U.S. and the 4th leading manufacturer of generic medicines globally. Within our Global Brands team, we are aggressively building a leadership position in Urology and Women’s health in the U.S. and expanding our portfolio internationally. We are also actively engaged in the development of biologics, ensuring Watson is well-positioned for future opportunity.

Impressive Financial Performance
Our net revenues continue to climb, increasing 28% to nearly $3.6 billion for full year 2010, compared to net revenue of $2.8 billion for full year 2009. 2011 revenues are forecast to increase to $4.5 billion.

Our Global Businesses
We operate and manage our business as three operating segments: Global Generics, Global Brands and Anda Distribution.

Global Generics
Our Global Generics team drives Watson’s prominence in the global generic pharmaceutical industry. With more than 160 product families in the U.S. and a significant number of product families in International Markets (Canada, U.K., France and various other markets across Europe, South Africa, Australia, the Pacific Rim and Latin America), our portfolio is among the broadest in the industry. We are focused on bringing to market value-added products that benefit consumers and enhance our market share around the world.

Global Brands
Our Global Brands team is leveraging our scientific and manufacturing expertise to develop innovative medicines for key therapeutic categories. We are building our leadership position in Urology and Women’s Health through a portfolio of more than 36 brand products, primarily sold in the U.S. Additionally, our Global Brands team has oversight for Watson’s emergence in biopharmaceuticals – the future of medicine and a significant opportunity for our Company. We are aggressively focused on enhancing the growth of this division through international expansion and key product launches.

Anda Distribution
A unique asset within our Global Supply Chain, Anda purchases and distributes generic and select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from more than 200 suppliers (including Watson) to more than 65,000 locations, including 11,000 physician accounts, approximately 17,000 independent pharmacies, and more than 35,000 chain locations. Anda’s skilled tele-sales force and outside national accounts team drive outstanding market coverage and sales volume, making more than 18,000 calls per day. Anda is the 4th largest distributor of generic medicines in the U.S.

Working at Watson
Watson offers one of the most exciting, challenging and rewarding work environments in the pharmaceutical industry. We are a dynamic, forward-thinking organization that is currently transforming itself from a U.S.-centric company to one that ranks as a global leader. This dramatic transformation is creating exciting and unique opportunities at all levels across our Company – opportunities that encourage individuals to grow, contribute, innovate and excel.

Our Winning Behaviors
Our Winning Behaviors is the foundation of Watson’s powerful global employee culture. By aligning ourselves around a common set of powerful action words - Challenge, Connect, Commit - we sharpen our individual and team focus; more effectively harness the collective talents of our team members; and work together to ensure Watson’s continued global success.

Career Opportunities at Watson
At Watson, you will find the ideal environment for applying your professional or technical passion. We welcome new and innovative ideas. And we provide the support and resources that enable you to take your career to new heights.

Learn more about career opportunities at Watson: www.WatsonCareers.com


 Key Statistics


Email:
Ownership: Public

Web Site: Watson Pharmaceuticals, Inc.
Employees:
Symbol: WPI
 



Industry
Pharmaceutical






 Company News
Ferring Pharmaceuticals Wins Lysteda Patent Lawsuit Against Watson Pharmaceuticals, Inc. (WPI), Apotex Corp. 2/4/2014 6:54:29 AM
Shire plc Wins Patent Trial Against Watson Pharmaceuticals, Inc. (WPI) Concerning LIALDA® 5/9/2013 10:40:49 AM
Shire plc Settles With Actavis (ACT), Watson Pharmaceuticals, Inc. (WPI) on ADHD Drug 4/25/2013 8:37:24 AM
Watson Pharmaceuticals, Inc. (WPI) is Now Actavis 1/24/2013 10:06:04 AM
Watson Pharmaceuticals, Inc. (WPI) Confirms Opana® ER Patent Challenge 1/23/2013 8:57:36 AM
Watson Pharmaceuticals, Inc. (WPI) to Acquire Uteron Pharma SA for Up to $305 Million 1/23/2013 7:07:12 AM
Watson Pharmaceuticals, Inc. (WPI) To Host 2013 Investor Meeting January 25 in New York 1/11/2013 7:44:46 AM
Watson Pharmaceuticals, Inc. (WPI)'s Generic Lysteda® Receives FDA Approval 1/3/2013 8:08:10 AM
Watson Pharmaceuticals, Inc. (WPI) Confirms Velcade® Patent Challenge 12/28/2012 9:15:52 AM
Watson Pharmaceuticals, Inc. (WPI) to Present at the 31st Annual J.P. Morgan Healthcare Conference 12/21/2012 7:26:23 AM
12345678910...